The Global Market for Flow Cytometry is Projected to Reach US$5.1 Billion by 2020
Expanding Application Areas to Drive the Global Flow Cytometry Market,
According to a New Report Update by Global
Industry Analysts, Inc.
GIA announces
the release of a comprehensive global report update on Flow Cytometry. The
global market for Flow Cytometry is projected to reach US$5.1 billion by 2020,
driven by expanding applications in hematology, oncology, and marine biology,
among others.
Flow cytometry
is an analytical laboratory technique that measures multiple parameters related
to individual particles or cells through the use of flow cytometers. Ranked among the most preferred tools in
single cell analysis, flow cytometry performs multiple measurements on a single
cell within a heterogeneous mixture, providing information about shape, size,
DNA content, cell count, fluorescence-activated cell sorting, surface
receptors, as well as membrane permeability. The technology finds significant use
in clinical as well as research settings for the analysis of both fixed and
live samples of cells, such as in government research, medical schools, academia,
clinical and hospital testing, independent testing and CROs.
Future growth
in the market will be driven by increasing research activity in various fields
of life sciences, such as genomics, proteomics, pharmacogenomics and stem cell
research. Small-sized, robust and high throughput flow cytometers designed for
use in a number of clinical and research applications are witnessing
significant demand worldwide. Flow cytometers are increasingly becoming compact
and smaller yet more powerful to address the broad range of high-end needs of
end users. Improvements in fluorescent dyes and advent of technically advanced
bench-top flow cytometers that offer the same performance and quality of
high-end instruments represent other key growth drivers in the market. Technological
advancements such as the introduction of multicolor flow cytometers with
multiple lasers are also fueling growth in the market. Factors such as
increasing affordability, ease of use and growth in reagent manufacturing have
made flow cytometry instruments more accessible worldwide leading to increased
market adoption. Additionally, introduction of new reagents targeted at
specific applications are driving growth in the flow cytometry reagents market.
As stated by
the new market research report on Flow Cytometry, the United States represents
the largest regional market worldwide. Asia-Pacific represents the fastest
growing market with a CAGR of about 13.4% over the analysis period. Steadily
growing economies, presence of large patient population, favorable government
policies, untapped market potential, and increasing investments in life sciences
research represent key growth drivers in the region. Cell-based flow cytometry
that measures the affinity of test compounds against a specific molecular
target in a living cell represents the largest flow cytometry technology
segment worldwide.
Key players covered
in the report include Becton, Dickinson and Company, Danaher/Beckman Coulter, Advanced
Analytical Technologies, Inc., Bangs Laboratories, Inc., Cytek Development,
Inc., eBioscience, Inc., EMD Millipore, Life Technologies Corporation, Luminex
Corp., Sysmex Partec GmbH, and PointCare Technologies, Inc., among others.
Comments
Post a Comment